Translating Immunopeptidomics to Immunotherapy‐Decision‐Making for Patient and Personalized Target Selection

Abstract excerpt

Immunotherapy is revolutionizing cancer treatment and has shown success in particular for tumors with a high mutational load. These effects have been linked to neoantigens derived from patient-specific mutations. To expand efficacious immunotherapy approaches to the vast majority of tumor types and patient populations carrying only a few mutations and maybe not a single presented neoepitope, it is necessary to...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Advanced biosensing and bioanalysis techniques
• Share to Peptidase Inhibition and Analysis
• Share to vaccines and immunoinformatics approaches